Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Biotech Stocks Well-Positioned For The Fourth Quarter
Article By:
Tarun Chandra, CFA
Wednesday, October 12, 2022 1:12 AM EDT
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
Article By:
ChinaBio® Today
Saturday, December 11, 2021 3:30 PM EDT
Regor Therapeutics entered a $1.55 billion research pact with Eli & Lilly to discover therapies for metabolic disorders. Meanwhile, Beijing Avistone Pharma received a $200 million investment led by Vivo Capital to combine with Pearl Biotech.
Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates
Article By:
Benzinga
Sunday, November 22, 2020 8:18 AM EDT
Biotech stocks came under pressure in the week ended Nov. 20, reversing course from the previous week. The sector started the week on a strong note, thanks to positive vaccine data reported by Moderna Inc.